AU2002235892A1 - Screening method for identifying medicaments - Google Patents

Screening method for identifying medicaments

Info

Publication number
AU2002235892A1
AU2002235892A1 AU2002235892A AU2002235892A AU2002235892A1 AU 2002235892 A1 AU2002235892 A1 AU 2002235892A1 AU 2002235892 A AU2002235892 A AU 2002235892A AU 2002235892 A AU2002235892 A AU 2002235892A AU 2002235892 A1 AU2002235892 A1 AU 2002235892A1
Authority
AU
Australia
Prior art keywords
screening method
medicaments
identifying
identifying medicaments
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002235892A
Inventor
Stefan Huber
Florian Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002235892A1 publication Critical patent/AU2002235892A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G01N2333/445—Plasmodium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2002235892A 2001-02-01 2002-02-01 Screening method for identifying medicaments Abandoned AU2002235892A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10104825A DE10104825A1 (en) 2001-02-01 2001-02-01 Antimalarial screening
DE10104825.4 2001-02-01
PCT/EP2002/001097 WO2002061421A2 (en) 2001-02-01 2002-02-01 Screening method for identifying medicaments

Publications (1)

Publication Number Publication Date
AU2002235892A1 true AU2002235892A1 (en) 2002-08-12

Family

ID=7672698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002235892A Abandoned AU2002235892A1 (en) 2001-02-01 2002-02-01 Screening method for identifying medicaments

Country Status (3)

Country Link
AU (1) AU2002235892A1 (en)
DE (1) DE10104825A1 (en)
WO (1) WO2002061421A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ305247B6 (en) * 2013-09-20 2015-07-01 Ústav molekulární genetiky AV ČR, v.v.i. Pharmaceutical composition containing diphenyleneiodonium for treating diseases caused by parasites of Trypanosomatidae species

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714380B1 (en) * 1993-12-24 1996-05-24 Bioxytech Use of 2-mercapto-imidazole derivatives substituted in position 4 (or 5) as antioxidants, their preparation process and their applications in pharmacy, cosmetics or food.
JPH0987196A (en) * 1995-09-25 1997-03-31 Masatoshi Nakano Parasite repellent
US5763496A (en) * 1995-11-27 1998-06-09 The Research Foundation Of State University Of New York Prevention of atherosclerosis using NADPH oxidase inhibitors
JPH09255589A (en) * 1996-03-28 1997-09-30 Shiseido Co Ltd Stress suppressant
GB9615202D0 (en) * 1996-07-19 1996-09-04 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
WO2002061421A3 (en) 2003-10-30
WO2002061421A2 (en) 2002-08-08
DE10104825A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
AU2002303584A1 (en) Method for identifying comparable instruments
AU2001267978A1 (en) Method for analyzing words
AU2003277663A1 (en) Screening method
AU2002249467A1 (en) Screening method
AU2002341150A1 (en) Method
AUPR966701A0 (en) Identification method
AU2002247215A1 (en) Method for screening compounds
AU2002258787A1 (en) Screening methods for identifying ligands
AU2002356482A1 (en) Strewing apparatus
AU2002235892A1 (en) Screening method for identifying medicaments
AUPR633101A0 (en) Method
AU2002354247A1 (en) Screening method
AU2002317009A1 (en) Screening method for identifying cancer therapy-relevant compounds
AU2002307540A1 (en) Method for evaluating personnel
AU2001258680A1 (en) Method for identifying biochemical material
AU2003217008A1 (en) Screening method
AU2003214103A1 (en) Method for identifying specific rna-inhibitors
AU2002321229A1 (en) Method for identifying anti-inflammatory drugs
AU2002330455A1 (en) Screening method
AU2002344589A1 (en) Screening method
AU2002230174A1 (en) Screening method
AU2002248009A1 (en) Screening method
AU2002253561A1 (en) Screening method
AU2002308962A1 (en) Screening method
AU2003248955A1 (en) Screening method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase